Neuromuscular blocking and cardiovascular effects of Org 9487, a new short-acting aminosteroidal blocking agent, in anaesthetized animals and in isolated muscle preparations

European Journal of Anaesthesiology

Volumn 15, Issue 4, 1998, Pages 467-479

  Muir, A W ^a   Sleigh, T ^a   Marshall, R J ^a   Pow, E ^a   Anderson, K A ^a   Booij, L H D J ^b   Hill, D R ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Haemodynamic effects; Neuromuscular blocking agents, pharmacology; Org 9487, suxamethonium, vecuronium

Indexed keywords

NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; NORADRENALIN; PYRIDOSTIGMINE; RAPACURONIUM BROMIDE; SUXAMETHONIUM; VECURONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR EFFECT; CAT; CONTROLLED STUDY; DOG; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG POTENCY; GANGLION BLOCK; HEMODYNAMICS; MONKEY; MUSCLE; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR SYNAPSE; NONHUMAN; VAGUS NERVE;

EID: 0031794546     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2346.1998.00310.x     Document Type: Article

References (38)

1. Hughes R. Experimental and clinical evaluation of neuromuscular blocking agents. J Pharmacol Methods 1984; 12: 1-27.
2. Marshall RJ, Muir AW, Sleigh T, Savage DS. The search for the nondepolarizing equivalent of suxamethonium. In: Denissen P, ed. The Development of Aminosteroidal Neuromuscular Blocking Agents. Turnhout, Belgium: Interface, 1992: 21-37.
3. Muir AW, Houston J, Marshall RJ, Bowman WC, Marshall IG. A comparison of the neuromuscular blocking and autonomic effects of two Short-acting muscle retaxants with those of suxamethonium in the anesthetized cat and pig. Anesthesiology 1989; 70: 533-540.
4. Booij LHDJ, Marshall IG, Crul JF, Muir AW. Pharmacology of four steroidal muscle relaxants. Abstracts of the 9th World Congress of Anesthesiologists, Washington, Vol II, A0533, 1988.
5. van den Broek L, Wierda JMKH, Proost JH, Hommes EDM, Agoston S. Clinical pharmacology of Org 7617, a short-acting nondepolarizing neuromuscular relaxant. Eur J Clin Pharmacol 1994; 46: 225-229.
6. Bowman WC, Rodger IW, Houston J, Marshall RJ, McIndewar IC. Structure:action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anaesthetized cat. Anesthesiology 1988; 62: 57-62.
7. Kopman AF. Pancuronium, gallamine and d-tubocurarine compared: is speed of onset inversely related to drug potency? Anesthesiology 1989; 70: 915-920.
8. Bevan DR, Kahwaji R, Shanks CA et al. Org 9487 - a new rapid onset muscle relaxant: dose ranging studies in adults. Anesth Analg 1996; 82: S27.
9. Motsch J, Meakin G, Meretoja OA, Schoenstedt R, Martin E. A dose ranging study of Org 9487 on endotracheal intubating conditions in infants and children. Anesthesiology 1995; 83: A919.
10. Bikhazi GB, Deepika KD, Fonseca J, Restrepo R, Shanmugam N. Cardiovascular effects of Org 9487 under nitrous oxide barbiturate anesthesia. Anesth Analg 1996; 82: S29.
11. Debaene B, Billard V, Lieutaud T, Meistelman C. Org 9487 neuromuscular block at the adductor pollicis muscle and laryngeal adductor muscles in humans. Anesthesiology 1996; 85: A1084.
12. Bulbring E. Observations on the isolated phrenic nerve-diaphragm preparation of the rat. Br J Pharmacol 1946; 1: 38-61.
13. Ginsborg BL, Warriner J. The isolated chick biventer cervicis nerve-muscle preparation. Br J Pharmacol 1960; 15: 410-411.
14. Muir AW, Houston J, Green K, Marshall RJ, Bowman WC, Marshall IG. Effects of a new neuromuscular blocking agent (Org 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations. Br J Anaesth 1989; 63: 400-410.
15. Booij LHDJ, Edwards RP, Soln YJ, Miller RD. Cardiovascular and neuromuscular effects of Org NC45, pancuronium, metocurine and d-tubocurarine in dogs. Anesth Analg 1980; 59: 26-30.
16. Walts LF. The 'boomerang'; a method of recording adductor pollicis tension. Can Anaesth Soc J 1973; 20: 706-708.
17. Ivankovich AD, Miletich DJ, Albrecht RF, Zahed B. The effect of pancuronium on myocardial contraction and catecholamine metabolism. J Pharm Pharmacol 1975; 27: 837-841.
18. Quintana A. Effect of pancuronium bromide on the adrenergic activity of the isolated rat vas deferens. Eur J Pharmacol 1977; 46: 275-277.
19. Docherty JR, McGrath JC. Sympathomimetic effects of pancuronium bromide on the cardiovascular system of the pithed rat: a comparison with the effects of drugs blocking the neuronal uptake of noradrenaline. Br J Pharmacol 1978; 64: 589-599.
20. Gillespie JS, MacLaren A, Pollock D. A method of stimulating different segments of the autonomic outflow from the spinal column to various organs in the pithed cat and rat. Br J Pharmacol 1970; 40: 257-257.
21. Brittain R, Tyers MB. The pharmacology of AH8165: a rapid-acting, short-lasting, competitive neuromuscular blocking drug. Br J Anaesth 1973; 45: 837-843.
22. Muir AW, Marshall RJ. Comparative neuromuscular blocking effects of vecuronium, pancuronium, Org 6368 and suxamethonium in the anaesthetized domestic pig. Br J Anaesth 1987; 59: 622-629.
23. Muir AW. The chloralose-anaesthetized pig as a model for testing neuromuscular blocking agents. PhD thesis, 1993.
24. Prior C, Tian L, El Mallah Al, Young L, Ward JM. Neuromuscular blocking profile of the vecuronium analogue, Org 9487, in the rat isolated hemidiaphragm preparation. Br J Pharmacol 1995; 116: 3049-3055.
25. Wierda JMKH, Beaufort AM, Kleef UW, Smeulers KJ, Agoston S. Preliminary investigations of the pharmacology of three short-acting nondepolarizing neuromuscular blocking agents Org 9453, Org 9489 and Org 9487. Can J Anaesth 1994; 41: 213-220.
26. Durant NN, Marshall IG, Savage DS, Nelson DJ, Sleigh T, Carlyle IC. The neuromuscular and autonomic blocking activities of pancuronium, Org NC 45 and other pancuronium analogues in the cat. J Pharm Pharmacol 1979; 31: 831-836.
27. Marshall IG, Gibb AJ, Durant NN. Neuromuscular and vagal blocking actions of pancuronium bromide, its metabolites, and vecuronium bromide (Org NC 45) and its potential metabolites in the anaesthetized cat. Br J Anaesth 1983; 55: 703-714.
28. Sutherland GA, Squire IB, Gibb AJ, Marshall IG. Neuromuscular and autonomic effects of vecuronium and atracurium in the anaesthetized cat. Br J Anaesth 1983; 55: 1119-1126.
29. Hughes R, Chapple DJ. Effect of nondepolarizing neuromuscular blocking agents on peripheral autonomic mechanism in cats. Br J Anaesth 1976; 48: 59-68.
30. Marshall IG. Actions of non-depolarizing neuromuscular blocking agents at cholinoceptors other than at the neuromuscular junction. In: Conseiller C, ed. Curares and Curarisation. North-Holland: Elsevier, 1980: 257-274.
31. Salt PJ, Barnes PK, Conway CM. Inhibition of neuronal uptake of noradrenaline in the isolated perfused rat heart by pancuronium and its homologues. Br J Anaesth 1980; 52: 313-317.
32. Fiddes S, Prior C. In-vitro smooth muscle relaxant activity of a series of vecuronium analogues in the rat aorta. J Pharm Pharmacol 1994; 46: 911-916.
33. Pollard BJ. What the relaxant does to the patient. In: Pollard DJ, ed. Applied Neuromuscular Pharmacology. Oxford University Press, 1994: 249-264.
34. Hof RP, Hof A, Scholtysik G, Menninger K. Effects of the new calcium antagonist PN-200-110 on the myocardium and regional peripheral circulation in anesthetized cats and dogs. J Cardiovasc Pharmacol 1984; 6: 407-416.
35. Drexler H, Truog AG, Just H, Zelis R. Effects of calcium blockade and converting enzyme inhibition on regional blood flow in a conscious rat model of heart failure. Klin Wochenschr 1985; 63: 262-267.
36. Wierda JMKH, van den Broek L, Proost JH, Verbaan BW, Hennis PJ. Time course of action and endotracheal intubating conditions of Org 9487, a new short-acting steroidal muscle relaxant; a comparison with succinylcholine. Anesth Analg 1993; 77: 579-584.
37. Caldwell JE, Robertson EN, Baird WLM. Antagonism of profound neuromuscular block induced by vecuronium and atracurium: comparison of neostigmine and edrophonium. Br J Anaesth 1986; 58: 1285-1289.
38. van den Broek L, Proost JH, Wierda JMKH. Early and late reversibility of rocuronium bromide. Eur J Anaesth 1994; 11(Suppl. 9): 128-132.